![Pharis Mohideen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pharis Mohideen
Chief Tech/Sci/R&D Officer at
DBV TECHNOLOGIES
Net worth: 568 518 $ as of 2026-05-30
Profile
Pharis Mohideen is currently Chief Medical Officer at DBV Technologies SA since 2019.
Former positions include Chief Medical Officer at Millendo Therapeutics, Inc. from 2014 to 2019; Vice President-Clinical Development at Shionogi, Inc. from 2012 to 2014; Global Head-Clinical Program at Novartis Oncology, Inc. from 2008 to 2012; Senior Director at Novartis International AG from 2006 to 2008; Principal at Bristol Myers Squibb Co.; Chief Medical Officer at Millendo Therapeutics US, Inc.; and Assistant Professor-Medicine at the University of Hawai'i at Hilo.
Education includes undergraduate, graduate, and doctorate degrees from the University of Hawai'i at Hilo and graduate studies at Vanderbilt University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
DBV TECHNOLOGIES SA 0.05% | 2026-04-14 | 144,995 ( 0.05% ) | 568 518 $ | 2026-05-30 |
Pharis Mohideen active positions
| Companies | Position | Start |
|---|---|---|
| DBV TECHNOLOGIES | Chief Tech/Sci/R&D Officer | 2019-07-21 |
Former positions of Pharis Mohideen
| Companies | Position | End |
|---|---|---|
| MILLENDO THERAPEUTICS | Chief Tech/Sci/R&D Officer | 2019-07-11 |
Shionogi, Inc.
 Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Corporate Officer/Principal | 2014-09-30 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 2011-12-31 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Corporate Officer/Principal | 2007-12-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Training of Pharis Mohideen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
26
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Millendo Therapeutics US, Inc.
 Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Health Technology |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hawai'i at Hilo
 University of Hawai'i at Hilo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Health Technology |
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Pharis Mohideen
